img

Global Cognitive Decline Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cognitive Decline Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Cognitive Decline report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cognitive Decline market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Mild Cognitive Impairment (MCI) and Dementia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cognitive Decline industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cognitive Decline key companies include Stryker, Smith & Nephew, Hill-Rom Services Inc., Paramount Bed Holdings Co., Ltd., ArjoHuntleigh, Talley Group Limited, Drive DeVilbiss Healthcare Ltd (Sidhil Limited), Apex Medical Corp. and Medtronic, etc. Stryker, Smith & Nephew, Hill-Rom Services Inc. are top 3 players and held % share in total in 2022.
Cognitive Decline can be divided into Cholinesterase Inhibitors and NMDA receptor antagonists, etc. Cholinesterase Inhibitors is the mainstream product in the market, accounting for % share globally in 2022.
Cognitive Decline is widely used in various fields, such as Mild Cognitive Impairment (MCI) and Dementia, etc. Mild Cognitive Impairment (MCI) provides greatest supports to the Cognitive Decline industry development. In 2022, global % share of Cognitive Decline went into Mild Cognitive Impairment (MCI) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cognitive Decline market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Stryker
Smith & Nephew
Hill-Rom Services Inc.
Paramount Bed Holdings Co., Ltd.
ArjoHuntleigh
Talley Group Limited
Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
Apex Medical Corp.
Medtronic
PROMA REHA, s. r. o.
Linet spol. S R.O.
DARCO International
DeRoyal Industries
BSN Medical (Essity)
Mölnlycke Health Care
TrueKAST (Wound Kair Concepts)
Thuasne SAS
DJO Global
ORTHOSERVICE AG
Breg, Inc.
Advanced Orthopaedics
ALGEOS
Hollister Incorporated
ConvaTec Group plc
Coloplast A/S
Medline Industries Inc.
Invacare Corporation
Segment by Type
by Drug Therapy
Cholinesterase Inhibitors
NMDA receptor antagonists
by Non-Invasive Stimulation Devices
Vagus Nerve Stimulators
Deep Brain Stimulators
Transcranial Magnetic Stimulators (TMSs)

Segment by Application


Mild Cognitive Impairment (MCI)
Dementia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Cognitive Decline market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Cognitive Decline introduction, etc. Cognitive Decline Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Cognitive Decline market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Cognitive Decline
1.1 Cognitive Decline Market Overview
1.1.1 Cognitive Decline Product Scope
1.1.2 Cognitive Decline Market Status and Outlook
1.2 Global Cognitive Decline Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Cognitive Decline Market Size by Region (2024-2034)
1.4 Global Cognitive Decline Historic Market Size by Region (2024-2024)
1.5 Global Cognitive Decline Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Cognitive Decline Market Size (2024-2034)
1.6.1 North America Cognitive Decline Market Size (2024-2034)
1.6.2 Europe Cognitive Decline Market Size (2024-2034)
1.6.3 Asia-Pacific Cognitive Decline Market Size (2024-2034)
1.6.4 Latin America Cognitive Decline Market Size (2024-2034)
1.6.5 Middle East & Africa Cognitive Decline Market Size (2024-2034)
2 Cognitive Decline Market by Type
2.1 Introduction
2.1.1 Cholinesterase Inhibitors
2.1.2 NMDA receptor antagonists
2.2 Global Cognitive Decline Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Cognitive Decline Historic Market Size by Type (2024-2024)
2.2.2 Global Cognitive Decline Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Cognitive Decline Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Cognitive Decline Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Cognitive Decline Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Cognitive Decline Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Cognitive Decline Revenue Breakdown by Type (2024-2034)
3 Cognitive Decline Market Overview by Application
3.1 Introduction
3.1.1 Mild Cognitive Impairment (MCI)
3.1.2 Dementia
3.2 Global Cognitive Decline Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Cognitive Decline Historic Market Size by Application (2024-2024)
3.2.2 Global Cognitive Decline Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Cognitive Decline Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Cognitive Decline Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Cognitive Decline Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Cognitive Decline Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Cognitive Decline Revenue Breakdown by Application (2024-2034)
4 Cognitive Decline Competition Analysis by Players
4.1 Global Cognitive Decline Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cognitive Decline as of 2022)
4.3 Date of Key Players Enter into Cognitive Decline Market
4.4 Global Top Players Cognitive Decline Headquarters and Area Served
4.5 Key Players Cognitive Decline Product Solution and Service
4.6 Competitive Status
4.6.1 Cognitive Decline Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Stryker
5.1.1 Stryker Profile
5.1.2 Stryker Main Business
5.1.3 Stryker Cognitive Decline Products, Services and Solutions
5.1.4 Stryker Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.1.5 Stryker Recent Developments
5.2 Smith & Nephew
5.2.1 Smith & Nephew Profile
5.2.2 Smith & Nephew Main Business
5.2.3 Smith & Nephew Cognitive Decline Products, Services and Solutions
5.2.4 Smith & Nephew Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.2.5 Smith & Nephew Recent Developments
5.3 Hill-Rom Services Inc.
5.3.1 Hill-Rom Services Inc. Profile
5.3.2 Hill-Rom Services Inc. Main Business
5.3.3 Hill-Rom Services Inc. Cognitive Decline Products, Services and Solutions
5.3.4 Hill-Rom Services Inc. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.3.5 Paramount Bed Holdings Co., Ltd. Recent Developments
5.4 Paramount Bed Holdings Co., Ltd.
5.4.1 Paramount Bed Holdings Co., Ltd. Profile
5.4.2 Paramount Bed Holdings Co., Ltd. Main Business
5.4.3 Paramount Bed Holdings Co., Ltd. Cognitive Decline Products, Services and Solutions
5.4.4 Paramount Bed Holdings Co., Ltd. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.4.5 Paramount Bed Holdings Co., Ltd. Recent Developments
5.5 ArjoHuntleigh
5.5.1 ArjoHuntleigh Profile
5.5.2 ArjoHuntleigh Main Business
5.5.3 ArjoHuntleigh Cognitive Decline Products, Services and Solutions
5.5.4 ArjoHuntleigh Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.5.5 ArjoHuntleigh Recent Developments
5.6 Talley Group Limited
5.6.1 Talley Group Limited Profile
5.6.2 Talley Group Limited Main Business
5.6.3 Talley Group Limited Cognitive Decline Products, Services and Solutions
5.6.4 Talley Group Limited Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.6.5 Talley Group Limited Recent Developments
5.7 Drive DeVilbiss Healthcare Ltd (Sidhil Limited)
5.7.1 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Profile
5.7.2 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Main Business
5.7.3 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Products, Services and Solutions
5.7.4 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.7.5 Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
5.8 Apex Medical Corp.
5.8.1 Apex Medical Corp. Profile
5.8.2 Apex Medical Corp. Main Business
5.8.3 Apex Medical Corp. Cognitive Decline Products, Services and Solutions
5.8.4 Apex Medical Corp. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.8.5 Apex Medical Corp. Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Cognitive Decline Products, Services and Solutions
5.9.4 Medtronic Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.9.5 Medtronic Recent Developments
5.10 PROMA REHA, s. r. o.
5.10.1 PROMA REHA, s. r. o. Profile
5.10.2 PROMA REHA, s. r. o. Main Business
5.10.3 PROMA REHA, s. r. o. Cognitive Decline Products, Services and Solutions
5.10.4 PROMA REHA, s. r. o. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.10.5 PROMA REHA, s. r. o. Recent Developments
5.11 Linet spol. S R.O.
5.11.1 Linet spol. S R.O. Profile
5.11.2 Linet spol. S R.O. Main Business
5.11.3 Linet spol. S R.O. Cognitive Decline Products, Services and Solutions
5.11.4 Linet spol. S R.O. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.11.5 Linet spol. S R.O. Recent Developments
5.12 DARCO International
5.12.1 DARCO International Profile
5.12.2 DARCO International Main Business
5.12.3 DARCO International Cognitive Decline Products, Services and Solutions
5.12.4 DARCO International Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.12.5 DARCO International Recent Developments
5.13 DeRoyal Industries
5.13.1 DeRoyal Industries Profile
5.13.2 DeRoyal Industries Main Business
5.13.3 DeRoyal Industries Cognitive Decline Products, Services and Solutions
5.13.4 DeRoyal Industries Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.13.5 DeRoyal Industries Recent Developments
5.14 BSN Medical (Essity)
5.14.1 BSN Medical (Essity) Profile
5.14.2 BSN Medical (Essity) Main Business
5.14.3 BSN Medical (Essity) Cognitive Decline Products, Services and Solutions
5.14.4 BSN Medical (Essity) Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.14.5 BSN Medical (Essity) Recent Developments
5.15 Mölnlycke Health Care
5.15.1 Mölnlycke Health Care Profile
5.15.2 Mölnlycke Health Care Main Business
5.15.3 Mölnlycke Health Care Cognitive Decline Products, Services and Solutions
5.15.4 Mölnlycke Health Care Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.15.5 Mölnlycke Health Care Recent Developments
5.16 TrueKAST (Wound Kair Concepts)
5.16.1 TrueKAST (Wound Kair Concepts) Profile
5.16.2 TrueKAST (Wound Kair Concepts) Main Business
5.16.3 TrueKAST (Wound Kair Concepts) Cognitive Decline Products, Services and Solutions
5.16.4 TrueKAST (Wound Kair Concepts) Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.16.5 TrueKAST (Wound Kair Concepts) Recent Developments
5.17 Thuasne SAS
5.17.1 Thuasne SAS Profile
5.17.2 Thuasne SAS Main Business
5.17.3 Thuasne SAS Cognitive Decline Products, Services and Solutions
5.17.4 Thuasne SAS Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.17.5 Thuasne SAS Recent Developments
5.18 DJO Global
5.18.1 DJO Global Profile
5.18.2 DJO Global Main Business
5.18.3 DJO Global Cognitive Decline Products, Services and Solutions
5.18.4 DJO Global Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.18.5 DJO Global Recent Developments
5.19 ORTHOSERVICE AG
5.19.1 ORTHOSERVICE AG Profile
5.19.2 ORTHOSERVICE AG Main Business
5.19.3 ORTHOSERVICE AG Cognitive Decline Products, Services and Solutions
5.19.4 ORTHOSERVICE AG Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.19.5 ORTHOSERVICE AG Recent Developments
5.20 Breg, Inc.
5.20.1 Breg, Inc. Profile
5.20.2 Breg, Inc. Main Business
5.20.3 Breg, Inc. Cognitive Decline Products, Services and Solutions
5.20.4 Breg, Inc. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.20.5 Breg, Inc. Recent Developments
5.21 Advanced Orthopaedics
5.21.1 Advanced Orthopaedics Profile
5.21.2 Advanced Orthopaedics Main Business
5.21.3 Advanced Orthopaedics Cognitive Decline Products, Services and Solutions
5.21.4 Advanced Orthopaedics Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.21.5 Advanced Orthopaedics Recent Developments
5.22 ALGEOS
5.22.1 ALGEOS Profile
5.22.2 ALGEOS Main Business
5.22.3 ALGEOS Cognitive Decline Products, Services and Solutions
5.22.4 ALGEOS Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.22.5 ALGEOS Recent Developments
5.23 Hollister Incorporated
5.23.1 Hollister Incorporated Profile
5.23.2 Hollister Incorporated Main Business
5.23.3 Hollister Incorporated Cognitive Decline Products, Services and Solutions
5.23.4 Hollister Incorporated Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.23.5 Hollister Incorporated Recent Developments
5.24 ConvaTec Group plc
5.24.1 ConvaTec Group plc Profile
5.24.2 ConvaTec Group plc Main Business
5.24.3 ConvaTec Group plc Cognitive Decline Products, Services and Solutions
5.24.4 ConvaTec Group plc Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.24.5 ConvaTec Group plc Recent Developments
5.25 Coloplast A/S
5.25.1 Coloplast A/S Profile
5.25.2 Coloplast A/S Main Business
5.25.3 Coloplast A/S Cognitive Decline Products, Services and Solutions
5.25.4 Coloplast A/S Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.25.5 Coloplast A/S Recent Developments
5.26 Medline Industries Inc.
5.26.1 Medline Industries Inc. Profile
5.26.2 Medline Industries Inc. Main Business
5.26.3 Medline Industries Inc. Cognitive Decline Products, Services and Solutions
5.26.4 Medline Industries Inc. Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.26.5 Medline Industries Inc. Recent Developments
5.27 Invacare Corporation
5.27.1 Invacare Corporation Profile
5.27.2 Invacare Corporation Main Business
5.27.3 Invacare Corporation Cognitive Decline Products, Services and Solutions
5.27.4 Invacare Corporation Cognitive Decline Revenue (US$ Million) & (2024-2024)
5.27.5 Invacare Corporation Recent Developments
6 North America
6.1 North America Cognitive Decline Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cognitive Decline Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Decline Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cognitive Decline Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Decline Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cognitive Decline Market Dynamics
11.1 Cognitive Decline Industry Trends
11.2 Cognitive Decline Market Drivers
11.3 Cognitive Decline Market Challenges
11.4 Cognitive Decline Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cognitive Decline Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Cognitive Decline Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Cognitive Decline Market Size Share by Region (2024-2024)
Table 4. Global Cognitive Decline Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Cognitive Decline Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Cognitive Decline Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Cognitive Decline Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Cognitive Decline Revenue Market Share by Type (2024-2024)
Table 9. Global Cognitive Decline Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Cognitive Decline Revenue Market Share by Type (2024-2034)
Table 11. North America Cognitive Decline Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Cognitive Decline Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Cognitive Decline Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Cognitive Decline Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Cognitive Decline Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Cognitive Decline Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Cognitive Decline Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Cognitive Decline Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Cognitive Decline Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Cognitive Decline Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Cognitive Decline Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Cognitive Decline Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Cognitive Decline Revenue Market Share by Application (2024-2024)
Table 24. Global Cognitive Decline Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Cognitive Decline Revenue Market Share by Application (2024-2034)
Table 26. North America Cognitive Decline Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Cognitive Decline Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Cognitive Decline Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Cognitive Decline Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Cognitive Decline Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Cognitive Decline Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Cognitive Decline Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Cognitive Decline Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Cognitive Decline Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Cognitive Decline Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Cognitive Decline Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Cognitive Decline Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cognitive Decline as of 2022)
Table 39. Date of Key Players Enter into Cognitive Decline Market
Table 40. Global Cognitive Decline Key Players Headquarters and Area Served
Table 41. Cognitive Decline Product Solution and Service
Table 42. Global Cognitive Decline Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Stryker Basic Information List
Table 45. Stryker Description and Business Overview
Table 46. Stryker Cognitive Decline Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cognitive Decline Business of Stryker (2024-2024)
Table 48. Stryker Recent Developments
Table 49. Smith & Nephew Basic Information List
Table 50. Smith & Nephew Description and Business Overview
Table 51. Smith & Nephew Cognitive Decline Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cognitive Decline Business of Smith & Nephew (2024-2024)
Table 53. Smith & Nephew Recent Developments
Table 54. Hill-Rom Services Inc. Basic Information List
Table 55. Hill-Rom Services Inc. Description and Business Overview
Table 56. Hill-Rom Services Inc. Cognitive Decline Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cognitive Decline Business of Hill-Rom Services Inc. (2024-2024)
Table 58. Hill-Rom Services Inc. Recent Developments
Table 59. Paramount Bed Holdings Co., Ltd. Basic Information List
Table 60. Paramount Bed Holdings Co., Ltd. Description and Business Overview
Table 61. Paramount Bed Holdings Co., Ltd. Cognitive Decline Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cognitive Decline Business of Paramount Bed Holdings Co., Ltd. (2024-2024)
Table 63. Paramount Bed Holdings Co., Ltd. Recent Developments
Table 64. ArjoHuntleigh Basic Information List
Table 65. ArjoHuntleigh Description and Business Overview
Table 66. ArjoHuntleigh Cognitive Decline Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cognitive Decline Business of ArjoHuntleigh (2024-2024)
Table 68. ArjoHuntleigh Recent Developments
Table 69. Talley Group Limited Basic Information List
Table 70. Talley Group Limited Description and Business Overview
Table 71. Talley Group Limited Cognitive Decline Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cognitive Decline Business of Talley Group Limited (2024-2024)
Table 73. Talley Group Limited Recent Developments
Table 74. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Basic Information List
Table 75. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Description and Business Overview
Table 76. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Cognitive Decline Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cognitive Decline Business of Drive DeVilbiss Healthcare Ltd (Sidhil Limited) (2024-2024)
Table 78. Drive DeVilbiss Healthcare Ltd (Sidhil Limited) Recent Developments
Table 79. Apex Medical Corp. Basic Information List
Table 80. Apex Medical Corp. Description and Business Overview
Table 81. Apex Medical Corp. Cognitive Decline Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cognitive Decline Business of Apex Medical Corp. (2024-2024)
Table 83. Apex Medical Corp. Recent Developments
Table 84. Medtronic Basic Information List
Table 85. Medtronic Description and Business Overview
Table 86. Medtronic Cognitive Decline Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cognitive Decline Business of Medtronic (2024-2024)
Table 88. Medtronic Recent Developments
Table 89. PROMA REHA, s. r. o. Basic Information List
Table 90. PROMA REHA, s. r. o. Description and Business Overview
Table 91. PROMA REHA, s. r. o. Cognitive Decline Products, Services and Solutions
Table 92. Revenue (US$ Million) in Cognitive Decline Business of PROMA REHA, s. r. o. (2024-2024)
Table 93. PROMA REHA, s. r. o. Recent Developments
Table 94. Linet spol. S R.O. Basic Information List
Table 95. Linet spol. S R.O. Description and Business Overview
Table 96. Linet spol. S R.O. Cognitive Decline Products, Services and Solutions
Table 97. Revenue (US$ Million) in Cognitive Decline Business of Linet spol. S R.O. (2024-2024)
Table 98. Linet spol. S R.O. Recent Developments
Table 99. DARCO International Basic Information List
Table 100. DARCO International Description and Business Overview
Table 101. DARCO International Cognitive Decline Products, Services and Solutions
Table 102. Revenue (US$ Million) in Cognitive Decline Business of DARCO International (2024-2024)
Table 103. DARCO International Recent Developments
Table 104. DeRoyal Industries Basic Information List
Table 105. DeRoyal Industries Description and Business Overview
Table 106. DeRoyal Industries Cognitive Decline Products, Services and Solutions
Table 107. Revenue (US$ Million) in Cognitive Decline Business of DeRoyal Industries (2024-2024)
Table 108. DeRoyal Industries Recent Developments
Table 109. BSN Medical (Essity) Basic Information List
Table 110. BSN Medical (Essity) Description and Business Overview
Table 111. BSN Medical (Essity) Cognitive Decline Products, Services and Solutions
Table 112. Revenue (US$ Million) in Cognitive Decline Business of BSN Medical (Essity) (2024-2024)
Table 113. BSN Medical (Essity) Recent Developments
Table 114. Mölnlycke Health Care Basic Information List
Table 115. Mölnlycke Health Care Description and Business Overview
Table 116. Mölnlycke Health Care Cognitive Decline Products, Services and Solutions
Table 117. Revenue (US$ Million) in Cognitive Decline Business of Mölnlycke Health Care (2024-2024)
Table 118. Mölnlycke Health Care Recent Developments
Table 119. TrueKAST (Wound Kair Concepts) Basic Information List
Table 120. TrueKAST (Wound Kair Concepts) Description and Business Overview
Table 121. TrueKAST (Wound Kair Concepts) Cognitive Decline Products, Services and Solutions
Table 122. Revenue (US$ Million) in Cognitive Decline Business of TrueKAST (Wound Kair Concepts) (2024-2024)
Table 123. TrueKAST (Wound Kair Concepts) Recent Developments
Table 124. Thuasne SAS Basic Information List
Table 125. Thuasne SAS Description and Business Overview
Table 126. Thuasne SAS Cognitive Decline Products, Services and Solutions
Table 127. Revenue (US$ Million) in Cognitive Decline Business of Thuasne SAS (2024-2024)
Table 128. Thuasne SAS Recent Developments
Table 129. DJO Global Basic Information List
Table 130. DJO Global Description and Business Overview
Table 131. DJO Global Cognitive Decline Products, Services and Solutions
Table 132. Revenue (US$ Million) in Cognitive Decline Business of DJO Global (2024-2024)
Table 133. DJO Global Recent Developments
Table 134. ORTHOSERVICE AG Basic Information List
Table 135. ORTHOSERVICE AG Description and Business Overview
Table 136. ORTHOSERVICE AG Cognitive Decline Products, Services and Solutions
Table 137. Revenue (US$ Million) in Cognitive Decline Business of ORTHOSERVICE AG (2024-2024)
Table 138. ORTHOSERVICE AG Recent Developments
Table 139. Breg, Inc. Basic Information List
Table 140. Breg, Inc. Description and Business Overview
Table 141. Breg, Inc. Cognitive Decline Products, Services and Solutions
Table 142. Revenue (US$ Million) in Cognitive Decline Business of Breg, Inc. (2024-2024)
Table 143. Breg, Inc. Recent Developments
Table 144. Advanced Orthopaedics Basic Information List
Table 145. Advanced Orthopaedics Description and Business Overview
Table 146. Advanced Orthopaedics Cognitive Decline Products, Services and Solutions
Table 147. Revenue (US$ Million) in Cognitive Decline Business of Advanced Orthopaedics (2024-2024)
Table 148. Advanced Orthopaedics Recent Developments
Table 149. ALGEOS Basic Information List
Table 150. ALGEOS Description and Business Overview
Table 151. ALGEOS Cognitive Decline Products, Services and Solutions
Table 152. Revenue (US$ Million) in Cognitive Decline Business of ALGEOS (2024-2024)
Table 153. ALGEOS Recent Developments
Table 154. Hollister Incorporated Basic Information List
Table 155. Hollister Incorporated Description and Business Overview
Table 156. Hollister Incorporated Cognitive Decline Products, Services and Solutions
Table 157. Revenue (US$ Million) in Cognitive Decline Business of Hollister Incorporated (2024-2024)
Table 158. Hollister Incorporated Recent Developments
Table 159. ConvaTec Group plc Basic Information List
Table 160. ConvaTec Group plc Description and Business Overview
Table 161. ConvaTec Group plc Cognitive Decline Products, Services and Solutions
Table 162. Revenue (US$ Million) in Cognitive Decline Business of ConvaTec Group plc (2024-2024)
Table 163. ConvaTec Group plc Recent Developments
Table 164. Coloplast A/S Basic Information List
Table 165. Coloplast A/S Description and Business Overview
Table 166. Coloplast A/S Cognitive Decline Products, Services and Solutions
Table 167. Revenue (US$ Million) in Cognitive Decline Business of Coloplast A/S (2024-2024)
Table 168. Coloplast A/S Recent Developments
Table 169. Medline Industries Inc. Basic Information List
Table 170. Medline Industries Inc. Description and Business Overview
Table 171. Medline Industries Inc. Cognitive Decline Products, Services and Solutions
Table 172. Revenue (US$ Million) in Cognitive Decline Business of Medline Industries Inc. (2024-2024)
Table 173. Medline Industries Inc. Recent Developments
Table 174. Invacare Corporation Basic Information List
Table 175. Invacare Corporation Description and Business Overview
Table 176. Invacare Corporation Cognitive Decline Products, Services and Solutions
Table 177. Revenue (US$ Million) in Cognitive Decline Business of Invacare Corporation (2024-2024)
Table 178. Invacare Corporation Recent Developments
Table 179. North America Cognitive Decline Market Size by Country (2024-2024) & (US$ Million)
Table 180. North America Cognitive Decline Market Size by Country (2024-2034) & (US$ Million)
Table 181. Europe Cognitive Decline Market Size by Country (2024-2024) & (US$ Million)
Table 182. Europe Cognitive Decline Market Size by Country (2024-2034) & (US$ Million)
Table 183. Asia-Pacific Cognitive Decline Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 184. Asia-Pacific Cognitive Decline Market Size by Region (2024-2024) & (US$ Million)
Table 185. Asia-Pacific Cognitive Decline Market Size by Region (2024-2034) & (US$ Million)
Table 186. Asia-Pacific Cognitive Decline Market Share by Region (2024-2024)
Table 187. Asia-Pacific Cognitive Decline Market Share by Region (2024-2034)
Table 188. Latin America Cognitive Decline Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 189. Latin America Cognitive Decline Market Size by Country (2024-2024) & (US$ Million)
Table 190. Latin America Cognitive Decline Market Size by Country (2024-2034) & (US$ Million)
Table 191. Middle East & Africa Cognitive Decline Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 192. Middle East & Africa Cognitive Decline Market Size by Country (2024-2024) & (US$ Million)
Table 193. Middle East & Africa Cognitive Decline Market Size by Country (2024-2034) & (US$ Million)
Table 194. Cognitive Decline Market Trends
Table 195. Cognitive Decline Market Drivers
Table 196. Cognitive Decline Market Challenges
Table 197. Cognitive Decline Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cognitive Decline Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Cognitive Decline Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Cognitive Decline Market Share by Regions: 2022 VS 2034
Figure 4. Global Cognitive Decline Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Cognitive Decline Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Cognitive Decline Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Cognitive Decline Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Cognitive Decline Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Cognitive Decline Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Cholinesterase Inhibitors
Figure 11. Global Cholinesterase Inhibitors Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of NMDA receptor antagonists
Figure 13. Global NMDA receptor antagonists Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Cognitive Decline Market Size Share by Type: 2022 & 2034
Figure 15. North America Cognitive Decline Revenue Market Share by Type (2024-2034)
Figure 16. Europe Cognitive Decline Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Cognitive Decline Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Cognitive Decline Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Cognitive Decline Revenue Market Share by Type (2024-2034)
Figure 20. Mild Cognitive Impairment (MCI) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Dementia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Global Cognitive Decline Market Size Share by Application: 2022 & 2034
Figure 23. North America Cognitive Decline Revenue Market Share by Application (2024-2034)
Figure 24. Europe Cognitive Decline Revenue Market Share by Application (2024-2034)
Figure 25. Asia-Pacific Cognitive Decline Revenue Market Share by Application (2024-2034)
Figure 26. Latin America Cognitive Decline Revenue Market Share by Application (2024-2034)
Figure 27. Middle East and Africa Cognitive Decline Revenue Market Share by Application (2024-2034)
Figure 28. Cognitive Decline Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 29. Global Top 5 and Top 10 Players Cognitive Decline Market Share in 2022
Figure 30. North America Cognitive Decline Market Share by Country (2024-2034)
Figure 31. U.S. Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 32. Canada Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 33. Germany Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 34. France Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 35. U.K. Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 36. Italy Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 37. Russia Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 38. Nordic Countries Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 39. Asia-Pacific Cognitive Decline Market Share by Region (2024-2034)
Figure 40. China Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 41. Japan Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 42. South Korea Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 44. India Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 45. Australia Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 46. Latin America Cognitive Decline Market Share by Country (2024-2034)
Figure 47. Mexico Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 48. Brazil Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Cognitive Decline Market Share by Country (2024-2034)
Figure 50. Turkey Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 52. UAE Cognitive Decline Market Size (2024-2034) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report